S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

AIM AIM ImmunoTech Inc

0.213

0.0039 (1.87%)

Last Updated: 01:32:42

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech Inc News

AIM ImmunoTech Announces Publication of Final Clinical Study Results for AMP-518 Clinical Trial on Ampligen as a Therapeutic for Post-COVID Conditions
Friday 24 January 2025 (5 days ago) • GlobeNewswire Inc.

AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
Thursday 23 January 2025 (6 days ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 January 2025 (7 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 18 January 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 18 January 2025 (2 weeks ago) • Edgar (US Regulatory)

AIM ImmunoTech Highlights Key 2024 Achievements and Outlines Upcoming 2025-26 Value-Driving Milestones
Thursday 16 January 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Tuesday 24 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 21 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 21 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 20 December 2024 (1 month ago) • Edgar (US Regulatory)

More AIM ImmunoTech Inc News Articles

Invesco QQQ Trust Series 1

S&P ASX 300 Metals and M...

Verizon Communications

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions